Dr. Zhou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
90 Presidential Plz
Fl 4
Syracuse, NY 13202Phone+1 315-464-4243
Summary
- Dr. Xiangping Zhou is a neurologist in Syracuse, NY and is affiliated with multiple hospitals in the area, including Upstate University Hospital and Syracuse Veterans Affairs Medical Center. She received her medical degree from Sun Yat-Sen University of Medical Science and has been in practice 23 years. She specializes in epilepsy and neurophysiology and is experienced in epilepsy, neurology, and clinical neurophysiology.
Clinical Expertise
- Epilepsy, Neurology, Refractory epilepsy, Clinical neurophysiology
Education & Training
National Capital ConsortiumFellowship, Clinical Neurophysiology, 2013 - 2014
Albany Medical CenterResidency, Neurology, 2010 - 2013- Albany Medical CenterInternship, Internal Medicine, 2009 - 2010
Sun Yat-Sen University of Medical ScienceClass of 1993
Certifications & Licensure
NY State Medical License 2017 - 2025
VA State Medical License 2013 - 2020
MO State Medical License 2015 - 2018
DC State Medical License 2013 - 2014- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Epilepsy
Publications & Presentations
PubMed
- 136 citationsThe interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway.Delia M. Talos, Hongyu Sun, Xiangping Zhou, Erin C. Fitzgerald, Michele Jackson
Plos One. 2012-05-02 - 31 citationsThe atypical antipsychotic quetiapine induces hyperlipidemia by activating intestinal PXR signalingZhaojie Meng, Taesik Gwag, Yipeng Sui, Se-Hyung Park, Xiangping Zhou
JCI Insight. 2019-02-07 - 8 citationsA Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency.John M. Schreiber, Edythe Wiggs, Rose Cuento, Gina Norato, Irene H. Dustin
Journal of Child Neurology. 2021-05-20
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
